discovered that among patients with MDS treated with immunotherapy plus HMA responders showed a trend towards increased TCR clonality after treatment, with a significantly higher frequency of novel clonotypes, while non-responders had a contracted TCR repertoire post-treatment.
← all excerpts
Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia.
1
—
—